Rhythm Pharmaceuticals Inc To Discuss On MC4R Pathway Programs Call Transcript
Thank you, everybody, for coming. I'm Dave Connolly here at Rhythm Pharmaceuticals, and thanks for coming to our R&D event this morning. We issued a press release today that provides details on today's update on MC4R pathway programs, and it is available on our website.
Our forward-looking statements disclosure slide here on slide 2, please read them. And with that in mind, I'll remind you, this event contains remarks concerning future expectations, plans, prospects which constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in our most recent annual or quarterly reports on file with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent dates. And we specifically disclaim any obligation to update such statements.
As a brief overview of today's event, I'll briefly introduce each of today's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
